Literature DB >> 23645381

Infliximab-related hepatitis: a case study and literature review.

Francisco Colina1, Aída Molero, Begoña Casís, Pilar Martínez-Montiel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23645381     DOI： 10.1007/s10620-013-2698-6

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  27 in total

1.  Infliximab-induced autoimmune hepatitis in Crohn's disease treated with budesonide and mycophenolate.

Authors:  K Subramaniam; S Chitturi; M Brown; P Pavli
Journal:  Inflamm Bowel Dis       Date:  2011-08-30       Impact factor: 5.325

2.  Infliximab therapy for Crohn's disease in a patient with chronic hepatitis B.

Authors:  Yoshitaka Ueno; Shinji Tanaka; Masaru Shimamoto; Yoshihiro Miyanaka; Toru Hiyama; Masanori Ito; Yasuhiko Kitadai; Masaharu Yoshihara; Masaharu Sumii; Kazuaki Chayama
Journal:  Dig Dis Sci       Date:  2005-01       Impact factor: 3.199

3.  [Infliximab-induced hepatitis in a patient with Crohn's disease].

Authors:  S Soto-Fernández; P González-Carro; A De Pedro-Esteban; M L Legaz-Huidobro; F Pérez-Roldán; O Roncero García-Escribano; M Valbuena-González; F Ruiz-Carrillo
Journal:  Gastroenterol Hepatol       Date:  2006-05       Impact factor: 2.102

4.  Hepatitis: a rare, but important, complication of infliximab therapy for psoriasis.

Authors:  S Wahie; A Alexandroff; N J Reynolds
Journal:  Clin Exp Dermatol       Date:  2006-05       Impact factor: 3.470

5.  Occult hepatitis B and infliximab-induced HBV reactivation.

Authors:  Salvatore Madonia; Ambrogio Orlando; Daniela Scimeca; Mirko Olivo; Francesca Rossi; Mario Cottone
Journal:  Inflamm Bowel Dis       Date:  2007-04       Impact factor: 5.325

6.  Efficiency and safety of etanercept after acute hepatitis induced by infliximab for psoriasis.

Authors:  Nicolas Kluger; Céline Girard; Bernard Guillot; Didier Bessis
Journal:  Acta Derm Venereol       Date:  2009       Impact factor: 4.437

7.  Autoimmune hepatitis induced by infliximab in a patient with Crohn's disease with no relapse after switching to adalimumab.

Authors:  Marilia Cravo; Rosa Silva; Miguel Serrano
Journal:  BioDrugs       Date:  2010-12-14       Impact factor: 5.807

8.  Infliximab-induced hepatitis: absence of cross-toxicity with etanercept.

Authors:  Gérard Thiéfin; Aude Morelet; Alexandra Heurgué; Marie-Daniele Diebold; Jean-Paul Eschard
Journal:  Joint Bone Spine       Date:  2008-08-06       Impact factor: 4.929

9.  Toxic hepatitis induced by infliximab in a patient with rheumatoid arthritis with no relapse after switching to etanercept.

Authors:  K M Carlsen; L Riis; O R Madsen
Journal:  Clin Rheumatol       Date:  2009-04-16       Impact factor: 2.980

10.  Successful treatment with etanercept in a patient with hepatotoxicity closely related to infliximab.

Authors:  Angel M García Aparicio; José Rey Rey; Azucena Hernández Sanz; Juana Sampedro Alvarez
Journal:  Clin Rheumatol       Date:  2006-07-07       Impact factor: 2.980
View more
  7 in total

Review 1.  Hepatotoxicity Associated with the Use of Anti-TNF-α Agents.

Authors:  Joshua B French; Maurizio Bonacini; Marwan Ghabril; David Foureau; Herbert L Bonkovsky
Journal:  Drug Saf       Date:  2016-03       Impact factor: 5.606

2.  Hepatotoxicity of anti-TNF agents.

Authors:  Maurizio Bonacini; Marwan Ghabril; Herbert L Bonkovsky
Journal:  Dig Dis Sci       Date:  2014-03-21       Impact factor: 3.199

3.  Infliximab leading to autoimmune hepatitis: an increasingly recognized side effect.

Authors:  Bulent Yilmaz; Emir Charles Roach; Seyfettin Koklu
Journal:  Dig Dis Sci       Date:  2014-10       Impact factor: 3.199

Review 4.  Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease.

Authors:  My-Linh Tran-Minh; Paula Sousa; Marianne Maillet; Matthieu Allez; Jean-Marc Gornet
Journal:  World J Hepatol       Date:  2017-05-08

5.  Fulminant Hepatic Failure in a Patient with Crohn's Disease on Infliximab Possibly Related to Reactivation of Herpes Simplex Virus 2 Infection.

Authors:  Gary Golds; Lawrence Worobetz
Journal:  Case Reports Hepatol       Date:  2016-10-12

Review 6.  Hepatobiliary manifestations of inflammatory bowel disease in children.

Authors:  Magdalena Kucharska; Urszula Daniluk; Kamila Agnieszka Kwiatek-Średzińska; Natalia Wasilewska; Aleksandra Filimoniuk; Piotr Jakimiec; Katarzyna Zdanowicz; Dariusz Marek Lebensztejn
Journal:  Clin Exp Hepatol       Date:  2019-09-05

Review 7.  Liver involvement in inflammatory bowel disease: What should the clinician know?

Authors:  Giuseppe Losurdo; Irene Vita Brescia; Chiara Lillo; Martino Mezzapesa; Michele Barone; Mariabeatrice Principi; Enzo Ierardi; Alfredo Di Leo; Maria Rendina
Journal:  World J Hepatol       Date:  2021-11-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.